Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
STERIS plc banner

STERIS plc
NYSE:STE

Watchlist Manager
STERIS plc Logo
STERIS plc
NYSE:STE
Watchlist
Price: 225.05 USD -0.78% Market Closed
Market Cap: $21.9B
Write Note Create Alert Ask AI

Wall St Price Targets

STE Price Targets Summary
STERIS plc

Wall Street analysts forecast STE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STE is 271.31 USD with a low forecast of 234.32 USD and a high forecast of 300.3 USD.

STE Lowest Forecast
Wall Street Target
$234.32
4% Upside
STE Average Forecast
Wall Street Target
$271.31
21% Upside
STE Highest Forecast
Wall Street Target
$300.3
33% Upside
Lowest Forecast
Price Target
234.32 USD
4% Upside
Average Forecast
Price Target
271.31 USD
21% Upside
Highest Forecast
Price Target
300.3 USD
33% Upside
STERIS plc Competitors:
Price Targets
FDMT
4D Molecular Therapeutics Inc
102% Upside
PXS
Pyxis Tankers Inc
64% Upside
ENTX
Entera Bio Ltd
205% Upside
NKTX
Nkarta Inc
296% Upside
FDMT
4D Molecular Therapeutics Inc
102% Upside
PXS
Pyxis Tankers Inc
64% Upside
ENTX
Entera Bio Ltd
205% Upside
NKTX
Nkarta Inc
296% Upside

Revenue
Forecast

11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 7%.

What are analyst estimates?

Gross Profit
Forecast

12% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
12% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 5 years is 7%.

What are analyst estimates?

Operating Income
Forecast

12% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
12% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 18%.

What are analyst estimates?

Pre-Tax Income
Forecast

12% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss
12% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 19%.

What are analyst estimates?

Net Income
Forecast

13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 5 years is 13%.

What are analyst estimates?

Continue STE Research

Summary
STE intrinsic value, competitors valuation, and company profile.
DCF Valuation
STE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
STE stock valuation using valuation multiples.
Wall St Estimates
STE price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
STE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other STERIS plc listings:
F • EUR
2TG
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is STE's stock price target?
Price Target
271.31 USD

According to Wall Street analysts, the average 1-year price target for STE is 271.31 USD with a low forecast of 234.32 USD and a high forecast of 300.3 USD.

What is the Revenue forecast for STERIS plc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 7%.

What is the Gross Profit forecast for STERIS plc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 5 years is 7%.

What is the Operating Income forecast for STERIS plc?
Projected CAGR
18%

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 18%.

What is the Pre-Tax Income forecast for STERIS plc?
Projected CAGR
19%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 19%.

What is the Net Income forecast for STERIS plc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 5 years is 13%.

Back to Top
ALPHA SPREAD
Follow us
Join 356,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett